SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations

Clinical trial NCT05393999 · WITHDRAWN

Trial details

NCT number: NCT05393999
Sponsor: Imperial College Healthcare NHS Trust
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

SARS-CoV2 Infection SARS-CoV-2 Acute Respiratory Disease Myeloma Leukemia Lymphoma Immune Thrombocytopenia Thrombotic Thrombocytopenic Purpura (TTP)

Start date: 2021-11-29
Primary completion: 2022-03-04
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.